Lymphocytic Toxicity in Patients After Peptide-Receptor Radionuclide Therapy (PRRT) with177Lu-DOTATATE and90Y-DOTATOC-Reference-Cited by-同舟云学术

Lymphocytic Toxicity in Patients After Peptide-Receptor Radionuclide Therapy (PRRT) with177Lu-DOTATATE and90Y-DOTATOC

Published:2009-12 Issue:6 Volume:24 Page:659-665
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Sierra Maribel L.¹,Agazzi Alberto²,Bodei Lisa¹,Pacifici Monica¹,Aricò Demetrio¹,De Cicco Concetta¹,Quarna Jessica²,Sansovini Maddalena³,De Simone Michele⁴,Paganelli Giovanni¹

Affiliation:

1. Nuclear Medicine Division, European Institute of Oncology, Milan, Italy.

2. Division of Hematology and Oncology Division, European Institute of Oncology, Milan, Italy.

3. Radiometabolic Medicine Division, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola (FC), Italy.

4. Surgical Oncology Department, Ospedale San Giuseppe, Empoli (FI), Italy.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2009.0641

Reference31 articles.

1. The somatostatin receptor family

2. Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors;Clinical Nuclear Medicine;2024-06-20

2. Evaluation of a blood miRNA/mRNA signature to follow-up Lu-PRRT therapy for G1/G2 intestinal neuroendocrine tumors;Frontiers in Endocrinology;2024-06-14

3. Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma;Cancers;2024-06-11

4. SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [¹⁷⁷Lu]Lu-DOTATATE;Journal of Nuclear Medicine;2024-03-28

5. Sequencing of Somatostatin-Receptor–Based Therapies in Neuroendocrine Tumor Patients;Journal of Nuclear Medicine;2024-01-18